home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Events -> Meetings and Conferences  

NGS Strategies for Vaccine Development and Surveillance of Respiratory Viruses

  April 12, 2024  
Xtalks, Online

In the landscape of infectious diseases, next-generation sequencing (NGS) has emerged as a transformative technology, offering unparalleled insights into the complex dynamics of respiratory RNA viruses and critical gene sequences associated with viral infection. This webinar delves into the multifaceted applications of NGS, spanning from viral typing and targeted gene sequencing to whole-genome analysis, with a particular focus on its utility in outbreak tracing and clinical diagnostics.

In this webinar, the expert speaker addresses the inherent challenges associated with analyzing low viral load clinical samples and offers strategies to enhance sensitivity and specificity in NGS-based assays. By leveraging whole-genome sequencing (WGS), NGS enables the simultaneous detection of multiple viral strains within a single sample, shedding light on the complex interplay between different pathogens and their implications for clinical management and public health interventions.

The attendees will gain insights into the intricacy of NGS assay development and validation where considerations such as workflow optimization and methodological choices, including probe-based versus amplicon sequencing, play pivotal roles in ensuring the accuracy and reliability of results.

The expert speaker will also provide a comprehensive overview of NGS tactics for analyzing respiratory RNA viruses and key gene sequences, thus highlighting their role in guiding clinical management, surveillance efforts and outbreak control measures.

Register for this webinar today to gain insights into NGS sequencing techniques tailored for analyzing respiratory RNA viruses with a focus on vaccine development.

Keywords: Vaccine, Drug Development, Infectious Disease, CRO, Respiratory Virus, Genomics, NGS, Respiratory Disease, RNA, Respiratory, Therapeutic Areas, Laboratory Technology, Vaccine Development, CDMO/CMO, Basic Research
Organized by: Xtalks
Invited Speakers: Kirthi Kumar Kutumbaka, PhD, Scientific Manager, Research & Development, Eurofins Viracor Biopharma Services
Deadline for Abstracts: 2024-05-01
Registration: Free Registration
E-mail: tristan@xtalks.com
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.